Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Regulatory News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.50
Bid: 3.00
Ask: 4.00
Change: -0.40 (-10.26%)
Spread: 1.00 (33.333%)
Open: 3.90
High: 0.00
Low: 0.00
Prev. Close: 3.90
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

23 Dec 2009 15:55

RNS Number : 6704E
Proteome Sciences PLC
23 December 2009
 



Proteome Sciences plc 

("Proteome Sciences" or "the Company")

Resignation of Director 

and 

Appointment of Chief Operating Officer

23rd December 2009: The Board of Proteome Sciences announces that Dr. Peter Schulz-Knappe will be leaving Proteome Sciences R&D GmbH & Co. KG on 31st December 2009 in order to be based more closely to his family, at which point he will resign as a director from the Company. The directors would like to thank Dr. Schulz-Knappe for his considerable contribution to the Company's progress and wish him every success in the future.

The Company is pleased to announce that Dr. Ian Pike has been appointed Chief Operating Officer of the Company and its subsidiaries and that Dr. Hans-Dieter Zucht has been appointed as Chief Technical Officer of Proteome Sciences R&D GmbH Co. KG in Frankfurt. Neither of these are appointments to the board of Proteome Sciences.

Ends

For further information please contact: 

Proteome Sciences plc

www.proteomics.com

Tel: +44 (0)1932 865065

Christopher Pearce, Chief Executive

James Malthouse, Finance Director 

Dr. Ian Pike, Chief Operating Officer

Email: christopher.pearce@proteomics.com

Email: james.malthouse@proteomics.com

Email: ian.pike@proteomics.com

Public Relations

IKON Associates 

Adrian Shaw

Tel: +44 (0)1483 271291

Mobile: +44 (0)797 9900733

Email: adrian@ikonassociates.com

Redleaf Communications Ltd. 

Samantha Robbins / Anna Dunkin 

Tel: +44 (0)20 7566 6700

Email: proteome@redleafpr.com

Nominated Adviser

Noble & Company Ltd.

John Llewellyn-Lloyd

Tel: +44 (0)20 7763 2200

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEXLFLKLBEFBZ
Date   Source Headline
24th Feb 20147:00 amRNSPlacing
7th Feb 20147:00 amRNSTrading Update
3rd Feb 20144:44 pmRNSHolding(s) in Company
27th Dec 20134:35 pmRNSPrice Monitoring Extension
4th Dec 20137:00 amRNSTrading Update
20th Nov 20137:00 amRNSPatient Stratification Biomarkers for Liver Cancer
6th Nov 20132:51 pmRNSHolding(s) in Company
1st Oct 201310:34 amRNSBlocklisting Interim Review
30th Sep 20137:00 amRNSHalf Yearly Report
18th Sep 20132:00 pmRNSKey Assay Development at HUPO
2nd Sep 201312:12 pmRNSHolding(s) in Company
6th Aug 201312:36 pmRNSIssue of Equity
18th Jul 20137:00 amRNSNew Data Shows CK1d Blocks Tau in AD Model
28th Jun 20131:00 pmRNSAGM Statement
28th Jun 20137:00 amRNSPatent Statement
26th Jun 20139:27 amRNSHolding(s) in Company
12th Jun 20137:00 amRNSMajor technology contract
5th Jun 20134:08 pmRNSAnnual Financial Report
30th May 20137:01 amRNSPreliminary Results
19th Apr 20137:00 amRNSTrading Update
2nd Apr 20137:00 amRNSBlock admission return
18th Mar 20137:00 amRNSDevelopments in Alzheimer's Disease
22nd Jan 20137:00 amRNSTrading Statement
31st Dec 20127:00 amRNSCK1D Update
3rd Dec 201211:06 amRNSHolding(s) in Company
28th Sep 20127:00 amRNSHalf Yearly Report
18th Sep 20124:04 pmRNSBlock Admission Return
18th Sep 20124:01 pmRNSBlock Admission Return
18th Sep 20127:00 amRNSFurther re. University of Geneva Study
20th Aug 20127:00 amRNSRe Agreement
29th Jun 201212:10 pmRNSAGM Statement
7th Jun 20123:10 pmRNSAnnual Financial Report
29th May 20127:00 amRNSFinal Results
30th Apr 20127:00 amRNSTotal Voting Rights
5th Apr 20127:00 amRNSStroke biomarker license to Randox
29th Mar 20125:11 pmRNSBlock Admission Return
28th Mar 20127:00 amRNSCompletion of Alzheimer's Plasma Biomarker Study
19th Mar 201210:00 amRNSEuroHYP EU Grant Award for Stroke
8th Mar 20128:55 amRNSHolding(s) in Company
5th Mar 20127:00 amRNSChange of Adviser
24th Feb 20124:24 pmRNSDirector/PDMR Shareholding
31st Jan 20127:00 amRNSTotal Voting Rights
18th Jan 20127:00 amRNSAdditional Listing
22nd Dec 20117:00 amRNSPromising hits against Alzheimer's Target
24th Nov 20117:00 amRNSNovel In Vitro Assays Developed
8th Nov 20113:39 pmRNSDirector Holdings
7th Oct 20117:00 amRNSBlock Admission Return
30th Sep 20117:00 amRNSInterim Results 2011
11th Aug 20114:35 pmRNSPrice Monitoring Extension
11th Aug 20111:33 pmRNSNotification of Major interest in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.